Skip to main content
EOFlow Co., Ltd. logo

EOFlow Co., Ltd. — Investor Relations & Filings

Ticker · 294090 ISIN · KR7294090006 KO Manufacturing
Open in API
Filings indexed 462 across all filing types
Latest filing 2021-02-08 Earnings Release
Country KR South Korea
Listing KO 294090

About EOFlow Co., Ltd.

https://www.eoflow.com

EOFlow Co., Ltd. is a medical device company that develops and provides wearable drug delivery solutions. Its flagship product is the EOPatch, a disposable, wearable insulin pump system designed for the continuous delivery of insulin to manage blood glucose levels in individuals with diabetes. The company leverages its proprietary technology and manufacturing expertise to create reliable and accessible drug delivery platforms. EOFlow also collaborates with partners to integrate its pump technology into automated insulin delivery (AID) systems, advancing diabetes care management.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (EOFlow) announcing a significant change (over 30%) in its financial results (revenue or profit/loss structure). This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. Since it provides specific financial highlights and reasons for the variance rather than just announcing the availability of a report, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial performance. FY 2020
2021-02-08 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a 'Major Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정). It details specific corrections to the terms of the bond, such as early redemption periods (Put Option) and call option periods. This is a regulatory filing submitted to the Financial Services Commission/Korea Exchange, which falls under the category of capital and financing updates.
2021-01-21 Korean
증권발행결과(자율공시)(제1회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the 'Results of Securities Issuance' (증권 발행결과) for a private placement of convertible bonds (CB). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of company fundraising and financing activities, which is classified as CAP (Capital/Financing Update).
2021-01-21 Korean
[기재정정]타법인주식및출자증권취득결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (EOFlow) regarding the acquisition of shares in another entity (Nephria Bio, Inc.). It is explicitly labeled as a 'Correction Report' (정정신고) for a previous 'Decision to Acquire Shares and Securities of Another Corporation' (타법인주식및출자증권취득결정). This type of disclosure regarding M&A activity, investment in subsidiaries, and capital allocation falls under the category of M&A Activity (TAR) within the provided schema.
2021-01-20 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This document details the terms of the financing, including interest rates, conversion prices, call/put options, and the use of proceeds. It is a formal regulatory filing detailing a capital structure change and financing activity, which falls under the 'Capital/Financing Update' category.
2021-01-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend or share issuance, it falls under the general regulatory filing category.
2020-12-10 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.